LUTINUS

Main information

  • Trade name:
  • LUTINUS Vaginal tablet 100MG
  • Dosage:
  • 100MG
  • Pharmaceutical form:
  • Vaginal tablet
  • Administration route:
  • Vaginal use
  • Units in package:
  • 90+APL Blister
  • Prescription type:
  • with prescription
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • LUTINUS Vaginal tablet 100MG
    Czech Republic
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • PROGESTERONE
  • Product summary:
  • LUTINUS

Other information

Status

  • Source:
  • SUKL - Státní ústav pro kontrolu léčiv
  • Authorization status:
  • R - active MA/authorised medicinal product
  • Authorization number:
  • 56/ 927/09-C
  • Last update:
  • 05-04-2018

6-5-2014

Guidance material to doctors and users of contraceptive pills

Guidance material to doctors and users of contraceptive pills

The EU Pharmacovigilance Risk Assessment Committee (PRAC) recently completed a review of the risk of blood clots (VTE) with contraceptive pills and other combined hormonal contraceptives. Combined hormonal contraceptives contain two types of hormone, oestrogen and progesterone, and are available as pills, transdermal patches and vaginal rings.

Danish Medicines Agency

There are no news related to this product.